Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,377,557
+$4,289,827 QoQ
Shares Held
478,120
+18.3% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#14
of 239 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Derivatives in NKTR
reported options exposure · as of Jun 30, 2026CallValue
$11,867,700
CallShares
170,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. NKTR ranks #34 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in NKTR
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,867,700 | 170,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $33,377,557 | 478,120 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $29,087,730 | 404,277 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,198,291 | 454,075 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $31,067,058 | 545,994 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $1,422,500 | 25,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $2,041,360 | 79,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $16,771,012 | 649,033 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,556,385 | 2,288,802 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,208,199 | 4,524,946 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,580,234 | 5,061,719 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,777,741 | 4,659,469 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,775,626 | 2,984,545 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $893,843 | 1,596,149 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $714,337 | 1,190,563 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,593,074 | 4,470,818 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $39,372 | 56,247 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,385,174 | 612,909 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $506,915 | 158,411 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $4,266,724 | 791,600 | Call | Sole | 2022-05-16 | |
| 2022-03-31 | $9,996,417 | 1,854,623 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,761,897 | 1,240,703 | Shares | Sole | 2022-02-14 | |
| 2021-12-31 | $2,057,573 | 152,300 | Put | Sole | 2022-02-14 | |
| 2021-12-31 | $4,179,994 | 309,400 | Call | Sole | 2022-02-14 | |
| 2021-09-30 | $11,798,875 | 656,953 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,890,835 | 576,389 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,158,060 | 107,903 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $10,554,246 | 620,838 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $1,700,000 | 100,000 | Call | Sole | 2021-02-16 | |
| 2020-09-30 | $1,852,655 | 111,673 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,165,274 | 93,492 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,391,453 | 133,975 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||